Vasoactive intestinal peptide (VIP) inhibits TGF-β1 production in murine macrophages
- 10 July 2000
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 107 (1), 88-99
- https://doi.org/10.1016/s0165-5728(00)00245-9
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cellsJournal of Neuroimmunology, 1999
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-JunPublished by Elsevier BV ,1998
- VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studiesJournal of Neuroimmunology, 1998
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Substance P Diminishes Lipopolysaccharide and Interferon-γ-Induced TGF-β1 Production by Cultured Murine MacrophagesCellular Immunology, 1998
- Neuropeptide Regulation of Cytokine Expression: Effects of VIP and Ro 25–1553Journal of Interferon & Cytokine Research, 1995
- Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complexJournal of Neuroimmunology, 1993
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Differential effect of transforming growth factor β on the synthesis of Th1‐ and Th2‐like lymphokines by human T lymphocytesEuropean Journal of Immunology, 1992
- Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-β2 gene reveals striking differences to the TGF-β1 and -β3 genesBiochemical and Biophysical Research Communications, 1990